OLIPHANT LAURA 4

What Happened
Laura Oliphant, a director of Aehr Test Systems (AEHR), sold 1,716 shares in an open-market/private sale on April 16, 2026. The shares were sold at $81.54 each for a total reported proceeds of $139,923. This was a sale (disposition), which is typically routine trading by insiders and does not by itself indicate company performance.

Key Details

• Transaction date: 2026-04-16; Filing date: 2026-04-17 (filed the next day; appears timely).
• Transaction type/code: Sale (S) — open market or private sale.
• Price per share: $81.54; Shares sold: 1,716; Proceeds: $139,923.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: Reported amount includes shares subject to unvested restricted stock units (RSUs).
• No 10b5-1 plan, tax-withholding, or late-filing flags were disclosed in the filing.

Context
Sales by directors are common and can reflect routine portfolio management (diversification, tax needs, etc.). Purchases generally provide stronger signals of insider conviction; this single sale should be viewed as factual disclosure rather than a definitive indicator of company outlook.